Pluri Inc. Common Stock
Symbol: PLUR (NASDAQ)
3.93
▼ (-4.03%) -0.165
Company Description:
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Key Stats
- Today's Open: $4.054
- Today's High: $4.054
- Today's Low: $3.615
- Today's Volume: 6.50K
- Yesterday Close: $4.09
- Yesterday High: $4.09
- Yesterday Low: $4.005
- Yesterday Volume: 5.76K
- Last Min Volume: 28
- Last Min High: $3.925
- Last Min Low: $3.925
- Last Min VWAP: $3.925
Company Profile
- Name: Pluri Inc. Common Stock
- Website: https://www.pluri-biotech.com
- Listed Date: 1991-10-09
- Location: HAIFA,
- Market Status: Active
- CIK Number: 0001158780
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $33.36M
- Round Lot: 100
- Outstanding Shares: 8.16M
- Asset Type: CS
RECENT FILINGS FOR PLUR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-16 | 4 | View |
| 2025-10-16 | 8-K | View |
| 2025-10-14 | SCHEDULE 13G/A | View |
| 2025-09-25 | EFFECT | View |
| 2025-09-22 | 3 | View |
| 2025-09-17 | S-3 | View |
| 2025-09-17 | S-8 | View |
| 2025-09-17 | S-8 | View |
| 2025-09-17 | 10-K | View |
| 2025-09-12 | 8-K | View |
| 2025-09-11 | 8-K | View |
| 2025-07-03 | 8-K | View |
| 2025-07-01 | 4 | View |
| 2025-06-09 | SCHEDULE 13D/A | View |
| 2025-05-28 | UPLOAD | View |
| 2025-05-27 | ARS | View |
| 2025-05-27 | DEF 14A | View |
| 2025-05-27 | 8-K | View |
| 2025-05-21 | CORRESP | View |
| 2025-05-20 | SCHEDULE 13D/A | View |
Latest News on PLUR